Literature DB >> 25366987

Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.

Shozo Sueda1, Toru Miyoshi2, Yasuhiro Sasaki2, Tomoki Sakaue2, Hirokazu Habara2, Hiroaki Kohno2.   

Abstract

We examined the safety of acetylcholine (ACh) and ergonovine (ER) tests retrospectively and investigated the optimal protocol of provocation test for diagnosis of multivessel coronary spasm. We performed 1546 ACh tests and 1114 ER tests during 23 years. ACh was injected in incremental doses of 20/50/80 μg into the right coronary artery (RCA) and of 20/50/100/200 μg into the left coronary artery (LCA) over 20 s. ER was administered in total doses of 40 μg into the RCA and of 64 μg into the LCA over 2-4 min. When a coronary spasm was induced and did not resolve spontaneously within 3 min after the completion of ACh/ER injection, or when hemodynamic instability due to coronary spasms occurred, 2.5-5.0 mg of nitrate was administered into the responsible vessel. To relive provoked spasm, it is necessary to administer nitrate in 31 cases by ACh and in 76 cases by ER (2.0 vs. 6.8 %, p < 0.01) before another vessel attempts. Multivessel spasms were often observed in LCA testing than in RCA testing on both agents [ACh: 78.6 % (11/14) vs. 11.8 % (2/17), p < 0.001, ER: 37.8 % (14/37) vs. 20.5 % (8/39), ns]. Even after the administration of nitrates, positive coronary spasm was obtained in 21.1 % by ACh and 52.9 % by ER tests on another coronary artery. No irreversible complications were recognized on both tests. We should firstly perform spasm provocation tests in the LCA and we may be able to diagnose another vessel spasm by performing the complete spasm provocation tests after the administration of nitrates to relieve provoked spasm in the first attempt.

Entities:  

Keywords:  Acetylcholine; Ergonovine; Nitrate; Spasm relief

Mesh:

Substances:

Year:  2014        PMID: 25366987     DOI: 10.1007/s00380-014-0591-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  20 in total

1.  Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine.

Authors:  S Sueda; H Fukuda; K Watanabe; N Ochi; H Kawada; Y Hayashi; T Uraoka
Journal:  Am J Cardiol       Date:  2001-09-01       Impact factor: 2.778

2.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  Long-term prognosis for patients with variant angina and influential factors.

Authors:  H Yasue; A Takizawa; M Nagao; S Nishida; M Horie; J Kubota; S Omote; K Takaoka; K Okumura
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

4.  Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm.

Authors:  K Okumura; H Yasue; K Matsuyama; K Goto; H Miyagi; H Ogawa; K Matsuyama
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

5.  Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association.

Authors:  Yusuke Takagi; Satoshi Yasuda; Ryusuke Tsunoda; Yasuhiro Ogata; Atsushi Seki; Tetsuya Sumiyoshi; Motoyuki Matsui; Toshikazu Goto; Yasuhiko Tanabe; Shozo Sueda; Toshiaki Sato; Satoshi Ogawa; Norifumi Kubo; Shin-ichi Momomura; Hisao Ogawa; Hiroaki Shimokawa
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-15

6.  Persistent coronary artery spasm documented by follow-up coronary angiography in patients with symptomatic remission of variant angina.

Authors:  Suk Min Seo; Pum Joon Kim; Dong Il Shin; Tae-Hoon Kim; Chan Jun Kim; Jin-soo Min; Yoon Seok Koh; Hun Jun Park; Dong Bin Kim; Sung-Ho Her; Ki-Yuk Chang; Sang Hong Baek; Wook Sung Chung; Ki-Bae Seung
Journal:  Heart Vessels       Date:  2012-04-19       Impact factor: 2.037

7.  Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina.

Authors:  M B Harding; M E Leithe; D B Mark; C L Nelson; J K Harrison; J B Hermiller; C J Davidson; D B Pryor; T M Bashore
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

8.  Limitations of medical therapy in patients with pure coronary spastic angina.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Kouki Watanabe; Naoto Ochi; Hiroyuki Kawada; Tadao Uraoka
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

9.  Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Naoto Ochi; Hiroyuki Kawada; Yutaka Hayashi; Tadao Uraoka
Journal:  Coron Artery Dis       Date:  2003-09       Impact factor: 1.439

10.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography.

Authors:  M E Bertrand; J M LaBlanche; P Y Tilmant; F A Thieuleux; M R Delforge; A G Carre; P Asseman; B Berzin; C Libersa; J M Laurent
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

View more
  8 in total

1.  The real world in the clinic before and after the establishment of guidelines for coronary artery spasm: a questionnaire for members of the Japanese Cine-angio Association.

Authors:  Shozo Sueda; Hiroaki Kohno; Hideaki Yoshino
Journal:  Heart Vessels       Date:  2016-12-05       Impact factor: 2.037

2.  Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2016-11-21       Impact factor: 2.037

3.  Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2016-12-22       Impact factor: 2.037

4.  Moderate vasomotor response to acetylcholine provocation test as an indicator of long-term prognosis.

Authors:  Masahiro Hoshino; Taishi Yonetsu; Akira Mizukami; Yuji Matsuda; Kenji Yoshioka; Yuta Sudo; Ryo Ninomiya; Masao Soeda; Shunsuke Kuroda; Maki Ono; Ryota Iwatsuka; Makoto Suzuki; Akihiko Matsumura; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2016-03-11       Impact factor: 2.037

5.  Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.

Authors:  Shozo Sueda; Toru Miyoshi; Ysuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

6.  Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging.

Authors:  Kiyoyasu Yamada; Satoshi Isobe; Hideki Ishii; Kazuhiko Yokouchi; Hirokazu Iwata; Ken Sawada; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2015-11-03       Impact factor: 2.037

7.  Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.

Authors:  Mitsunobu Kitamura; Noritake Hata; Tadateru Takayama; Atsushi Hirayama; Masashi Ogawa; Akira Yamashina; Hisaaki Mera; Hideaki Yoshino; Fumitaka Nakamura; Yoshihiko Seino
Journal:  Heart Vessels       Date:  2015-06-17       Impact factor: 2.037

8.  Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: Two case reports.

Authors:  Remi Goto-Semba; Yuichi Fujii; Tomohiro Ueda; Chikage Oshita; Hiroki Teragawa
Journal:  World J Cardiol       Date:  2018-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.